Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stem (STEM) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Stem (STEM) over the last 6 years, with Q2 2025 value amounting to $1.4 million.

  • Stem's Asset Writedowns and Impairment fell 5483.87% to $1.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 20063.17%. This contributed to the annual value of $14.7 million for FY2024, which is 21219.15% up from last year.
  • Stem's Asset Writedowns and Impairment amounted to $1.4 million in Q2 2025, which was down 5483.87% from $12.6 million recorded in Q4 2024.
  • In the past 5 years, Stem's Asset Writedowns and Impairment registered a high of $12.6 million during Q4 2024, and its lowest value of -$1.0 million during Q1 2024.
  • Over the past 5 years, Stem's median Asset Writedowns and Impairment value was $900000.0 (recorded in 2023), while the average stood at $1.7 million.
  • Within the past 5 years, the most significant YoY rise in Stem's Asset Writedowns and Impairment was 43450.91% (2024), while the steepest drop was 21155.56% (2024).
  • Stem's Asset Writedowns and Impairment (Quarter) stood at $2.1 million in 2021, then decreased by 19.06% to $1.7 million in 2022, then surged by 37.12% to $2.4 million in 2023, then surged by 434.51% to $12.6 million in 2024, then tumbled by 88.87% to $1.4 million in 2025.
  • Its Asset Writedowns and Impairment stands at $1.4 million for Q2 2025, versus $12.6 million for Q4 2024 and $300000.0 for Q3 2024.